Clinical Trials on Gram-negative Bacteraemia

Total 6693 results

University Hospital Center of Martinique
Centre Hospitalier Universitaire de la Réunion; Centre Hospitalier de Cayenne; University Hospital of Guadeloupe and other collaborators

Recruiting

Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte) (LEPTO3)

Mild Leptospirosis

Martinique, French Guiana, Guadeloupe, Mayotte, Réunion
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Meningococcal Infections

Czechia, Finland, Italy, Poland, Romania, Spain, Sweden
Groupe Hospitalier de la Rochelle Ré Aunis

Completed

Epidemiology Non-cholera Vibrio Infections (INFECTIVE)

Vibrio Infections

France
U.S. Army Medical Research and Development Command

Enrolling by invitation

Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
University of Sao Paulo General Hospital
Instituto de Infectologia Emílio Ribas

Completed

Correlation Between Cytokines and the Severity of Meningococcal Disease

Meningococcemia

Brazil
McGill University Health Centre/Research Institute...

Completed

Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia (DASH)

Bacteremia | Methicillin Susceptible Staphylococcus Aureus Septicemia

Canada
Hospices Civils de Lyon

Recruiting

Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study (Campylo-BJI)

Campylobacter Infections

France
Soroka University Medical Center
Ben-Gurion University of the Negev

Recruiting

Investigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic Technologies

Brucellosis | Zoonotic Disease

Israel
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Meningococcal Infections

Finland
Khon Kaen University

Unknown

Clinical Presentation of Melioidosis in Head and Neck Region

Melioidosis | Head and Neck Infection

Thailand
Il-Yang Pharm. Co., Ltd.

Completed

Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection

Helicobacter Infections

Korea, Republic of
American University of Beirut Medical Center

Completed

A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection

Helicobacter Infections

Lebanon
Hospital Authority, Hong Kong
GlaxoSmithKline

Suspended

A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult

Sepsis | Gram-Negative Bacterial Infections

China
José Raimundo Araujo de Azevedo

Not yet recruiting

Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Antimicrobial Resistance
Erasmus Medical Center
Radboud University Medical Center; National Institute for Public Health and... and other collaborators

Not yet recruiting

Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia (QUINDO)

Drug Resistance, Microbial
Nanjing First Hospital, Nanjing Medical University

Recruiting

Fucoidan Assisted Eradication of Helicobacter Pylori

Helicobacter Pylori Infection | Intestinal Bacteria Flora Disturbance

China
EuBiologics Co.,Ltd

Completed

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Infection, Meningococcal

Korea, Republic of
London School of Hygiene and Tropical Medicine

Completed

Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo

Diarrhea | Cholera

Congo, The Democratic Republic of the
UMC Utrecht
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2) (EXPECT-2)

E. Coli Infection

United States, Italy, United Kingdom, Canada, France, Germany, Japan, Spain
GlaxoSmithKline

Completed

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Infections, Meningococcal | Meningococcal Vaccines

India, Lebanon, Philippines, Saudi Arabia
GlaxoSmithKline

Completed

A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)

Meningococcal Disease | Infections, Meningococcal

Colombia, Panama, Chile
GlaxoSmithKline

Completed

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

Meningococcal Disease | Infections, Meningococcal

United States
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine (HOPS)

Meningococcal Infection, Group B

United States
International Vaccine Institute
International Centre for Diarrhoeal Disease Research, Bangladesh; Christian... and other collaborators

Terminated

Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants

Diarrhea | Cholera | Vibrio Infections

Bangladesh, India
Centers for Disease Control and Prevention
Food and Drug Administration (FDA); Ministry of Health, Uganda; Ministry of Health...

Completed

Treatment and Diagnosis of Plague

Plague

Madagascar
Johns Hopkins Bloomberg School of Public Health
National Institute of Allergy and Infectious Diseases (NIAID); International... and other collaborators

Recruiting

Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)

Diarrhea | Cholera

Bangladesh
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy

Healthy Volunteers | Meningococcal Immunisation

Argentina
University of Florida
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Next Generation ORS: Controlled Trial Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea (ORS)

Diarrhea | Cholera

Bangladesh
Institut Pasteur

Recruiting

Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia (LEPJARNC)

Leptospirosis | Jarisch Herxheimer Reaction

New Caledonia
Suez Canal University

Completed

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

Escherichia Coli Infections

Egypt
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa (MET55)

Healthy Volunteers (Meningococcal Infection)

India, South Africa
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom (MET52)

Healthy Volunteers (Meningococcal Infection)

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico (MET33)

Healthy Volunteers (Meningococcal Infection)

Mexico, Russian Federation
Sanofi

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Meningococcal Immunisation (Healthy Volunteers)

Japan
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon (MEQ00063)

Healthy Volunteers (Meningococcal Infection)

Lebanon, Turkey
EuBiologics Co.,Ltd

Completed

Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old

Infection, Meningococcal

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

Infections, Meningococcal | Meningococcal Vaccines

Estonia, Germany, Spain
PATH

Completed

PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera (PISCES)

Diarrhea | Cholera

Bangladesh
International Vaccine Institute
Indian Council of Medical Research; Institute of Child Health; National Institute... and other collaborators

Unknown

Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants

Diarrhea | Cholera | Vibrio Infections

India
Atlantia Food Clinical Trials

Completed

Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion

HELICOBACTER INFECTION

Ireland
International Vaccine Institute
National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics...

Completed

Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata

Diarrhea | Cholera | Vibrio Infections

India
International Vaccine Institute
Bill and Melinda Gates Foundation; World Health Organization; National Institute... and other collaborators

Completed

Mass Oral Cholera Vaccination in Zanzibar

Diarrhea | Cholera

Tanzania
International Vaccine Institute
National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics...

Completed

Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine

Diarrhea | Cholera | Vibrio Infections

India
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age

Meningitis | Meningococcal Infection

United States
Adaptive Phage Therapeutics, Inc.

No longer available

Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia

Covid19 | Bacteremia | Septicemia | Pseudomonas Aeruginosa Infection | Acinetobacter Baumannii Infection | Staph Aureus Infection
Hunazine Biotech S.L.

Recruiting

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Cholera

Bangladesh
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (MEQ00064)

Healthy Volunteers | Meningococcal Immunisation

South Africa, India
Liaocheng People's Hospital

Not yet recruiting

Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine

Helicobacter Pylori Infection | Traditional Chinese Medicine | Eradication
International Centre for Diarrhoeal Disease Research...
Stanford University; Centers for Disease Control and Prevention

Recruiting

Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine

Vaccine Reaction

Bangladesh
Sanofi Pasteur, a Sanofi Company

Completed

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

Healthy Volunteers | Meningococcal Infection

Vietnam

Clinical Trials on Gram-negative Bacteraemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations